| 1. |
1 [No authors listed]. Management of unstable angina. Guidelines--2000. The National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand.
Med J Aust
, 2000, 173 Suppl: S65-88.
|
| 2. |
2 Roger VL, Killian JM, Weston SA,
et al
. Redefinition of myocardial infarction: prospective evaluation in the community.
Circulation
, 2006, 114(8): 790-797.
|
| 3. |
3 Hamm CW, Goldmann BU, Heeschen C,
et al
. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.
N Engl J Med
, 1997, 337(23): 1648-1653.
|
| 4. |
4 Figiel, Kasprzak JD, Peruga J,
et al
. Heart-type fatty acid binding protein — a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Kardiol Pol
, 2008, 66(3): 253-258.
|
| 5. |
6 Eagle KA, Lim MJ, Dabbous OH,
et al
. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.
JAMA
, 2004, 291(22): 2727-2733.
|
| 6. |
7 Roy D, Quiles J, Aldama G,
et al
. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.
Int J Cardiol
, 2004, 97(2): 297-301.
|
| 7. |
8 Peacock F, Morris DL, Anwaruddin S,
et al
. Meta-analysis of ischemiamodified albumin to rule out acute coronary syndromes in the emergency department.
Am Heart J
, 2006, 152(2): 253-262.
|
| 8. |
9 Bar-Or D, Lau E, Winkle JV. A novel assay for cobalt-albumin binding and its potential as a maker for myocardial ischemia pre-liminary report.
J Emerg Med
, 2000, 19(4): 311-315.
|
| 9. |
10 Sinha MK, Gaze DC, Tippins IR,
et al
. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
Circulation
, 2003, 107(19): 2403-2405.
|
| 10. |
11 de Filippi C, Yoon S, Ro A. Early detection of myocardial ischemia by a novel blood based biomarker: the kinetics of ischemia modified albumin.
J Am Coll Cardiol
, 2003, 41: 6(suppl. A): 340A.
|
| 11. |
12 Roy D, Quiles J, Aldama G, Sinha M,
et al
. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiaograms and negative cardiac troponin T.
Int J Cardiol
, 2004, 97(2): 297-301.
|
| 12. |
13 Christeson RH, Duh SH,
et al
. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study.
Clin Chem
, 2001, 47(3): 464-470.
|
| 13. |
14 Peacock F, Morris DL, Anwaruddin S,
et al
. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.
Am Heart J
, 2006, 152(2): 253-262.
|
| 14. |
15 Consuegra-Sanchez L, Bouzas-Mosguera A, Sinha MK,
et al
. Ischemia modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain.
Heart Vessels
, 2008; 23(3): 174-180.
|
| 15. |
16 Worster A, Devereaux PJ, Heels-Ausdell D,
et al
. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome.
CMAJ
, 2005, 172(13): 1685-1690.
|
| 16. |
李麗, 高大勝. 缺血修飾白蛋白在冠心病臨床應用中的研究進展. 中國急救醫學, 2008, 28(8): 745-748.
|
